1-11 of 11
James M. Reuben, PhD
Close
Sort by
Journal Articles

Correlation Between Clinical Responses and Immune Characteristics in Patients with Relapsed CLL Treated with Ofatumumab and Lenalidomide

Candida Vitale, MD, Lorenzo Falchi, MD, Elisa ten Hacken, PhD, Hui Gao, PhD, Hila Shaim, MD, Katrien Van Roosbroeck, PhD, George Calin, MDPhD, Susan O'Brien, MD, Stefan Faderl, MD, Xuemei Wang, MS, William Wierda, MD PhD, Katayoun Rezvani, MDPhD, James M Reuben, PhD, Jan A. Burger, MD PhD, Michael Keating, MBBS, Alessandra Ferrajoli, MD
Journal: Blood
Blood (2015) 126 (23): 1748.
https://doi.org/10.1182/blood.V126.23.1748.1748
Published: 2015
Journal Articles

Serum miRNA Expression and Allogeneic Stem Cell Transplantation in Patients with B Chronic Lymphocytic Leukemia (CLL)

Issa F. Khouri, MD, Simone Anfossi, PhD, Rima M Saliba, PhD, Lisa S. St. John, PhD, Jeffrey J. Molldrem, MD, James M Reuben, PhD
Journal: Blood
Blood (2014) 124 (21): 5791.
https://doi.org/10.1182/blood.V124.21.5791.5791
Published: 2014
Journal Articles

Therapy-Related Myeloid Neoplasms in Breast Cancer Patients: A Single-Institution Report of 150 Cases

Katarina Sevcikova, MD, Zuo Zhuang, MD PhD, Guillermo Garcia-Manero, MD, Ricardo Alvarez, MD, Hagop M. Kantarjian, MD, Mego Michal, MD, Constance Albarracin, MD PhD, Guilin Tang, MD, Sara S. Strom, PhD, James M. Reuben, PhD, Joseph D Khoury, MD
Journal: Blood
Blood (2014) 124 (21): 962.
https://doi.org/10.1182/blood.V124.21.962.962
Published: 2014
Journal Articles

Ofatumumab Plus Chemotherapy Followed By G-CSF For Mobilization Of Peripheral Blood Stem Cells (PBSC) In Patients With B-Cell Non-Hodgkin’s Lymphomas (NHL)

Issa F. Khouri, MD, Hui Gao, PhD, Wei Wei, MS, Martin Korbling, MD, Celina Ledesma, BS, Rosamar Valverde, MD, Alison M Gulbis, PharmD, BCOP, James M Reuben, PhD
Journal: Blood
Blood (2013) 122 (21): 4518.
https://doi.org/10.1182/blood.V122.21.4518.4518
Published: 2013
Journal Articles

Long-Lasting Responses with Lenalidomide As Initial Therapy of Elderly Patients with Chronic Lymphocytic Leukemia (CLL)

Paolo Strati, Michael J. Keating, MD, William G. Wierda, MD, PhD, Xavier C. Badoux, MBBS, Steliana Calin, MD, James M. Reuben, PhD, Susan M. O'Brien, MD, Steven M. Kornblau, MD, Hagop M. Kantarjian, MD, Bang-Ning Lee, PhD, PA-C, Alessandra Ferrajoli, M.D.
Journal: Blood
Blood (2012) 120 (21): 3932.
https://doi.org/10.1182/blood.V120.21.3932.3932
Published: 2012
Journal Articles

Significant Changes in Inducible Cytokine Synthesis by Activated Peripheral Blood Leukocytes of Multiple Myeloma Patients Receiving Standard Dose Autologous Stem Cell Transplantation

Bang-Ning Lee, PhD, PA-C, Nina Shah, MD, Sergio Giralt, MD, Hui Gao, PhD, Evan N Cohen, BS, Lori Williams, PhD, Ibrahima Gning, Tito R Mendoza, PhD, Jane O Brown, RN, Valen E Johnson, PhD, Richard Champlin, MD, Charles S Cleeland, PhD, James M Reuben, PhD
Journal: Blood
Blood (2011) 118 (21): 5096.
https://doi.org/10.1182/blood.V118.21.5096.5096
Published: 2011
Journal Articles

The Longitudinal Relationship Between Inflammatory Markers and Patient-Reported Symptom Severity During Induction Therapy for Multiple Myeloma

Xin Shelley Wang, MD, MPH, Ping Liu, MS, Charles S Cleeland, PhD, James M Reuben, PhD, Evan N Cohen, BS, Lori Williams, PhD, Gary M Mobley, MA, Jacqueline Joy, MS, CCRP, Venus M Ilagan, BS, Katherine R Gilmore, MPH, CCRP, Tito R Mendoza, PhD, Valen E Johnson, PhD
Journal: Blood
Blood (2011) 118 (21): 4920.
https://doi.org/10.1182/blood.V118.21.4920.4920
Published: 2011
Journal Articles

Combination Therapy with Lenalidomide and Rituximab in Patients with Relapsed Chronic Lymphocytic Leukemia (CLL).

Alessandra Ferrajoli, MD, Xavier C. Badoux, MBBS, Susan O'Brien, MD, William G. Wierda, MD, PhD, Stefan Faderl, MD, Zeev Estrov, MD, Manolo Pasia, RN, Bang-Ning Lee, PhD, James M. Reuben, PhD, Hagop Kantarjian, MD, Michael Keating, MD
Journal: Blood
Blood (2009) 114 (22): 206.
https://doi.org/10.1182/blood.V114.22.206.206
Published: 2009
Journal Articles

Treatment with Lenalidomide Has a Positive Immunomodulatory Effect in Patients with Chronic Lymphocytic Leukemia.

Hui Gao, PhD, Alessandra Ferrajoli, MD, Evan N Cohen, Bang-Ning Lee, PhD, Sanda Tin, M.D., Susan O’Brien, M.D., William G. Wierda, M.D., Ph.D, Zeev Estrov, M.D., Stefan Faderl, MD, Michael J Keating, M.D., James M. Reuben, PhD
Journal: Blood
Blood (2008) 112 (11): 2107.
https://doi.org/10.1182/blood.V112.11.2107.2107
Published: 2008
Journal Articles

Lenalidomide Induces Complete and Partial Responses in Patients with Relapsed and Treatment-Refractory Chronic Lymphocytic Leukemia (CLL).

Alessandra Ferrajoli, MD, Susan M. O’Brien, MD, Stefan H. Faderl, MD, William G. Wierda, MD, PhD, Dietrich Davis, RN, Bang-Ning Lee, PhD, James M. Reuben, PhD, Ellen J. Schlette, MD, Hagop M. Kantarjian, MD, Michael J. Keating, MBBS
Journal: Blood
Blood (2006) 108 (11): 305.
https://doi.org/10.1182/blood.V108.11.305.305
Published: 2006
Journal Articles

RhG-CSF Mobilized and Apheresis-Collected Endothelial Progenitor Cells for Therapeutic Vasculogenesis.

Martin Korbling, MD, James M. Reuben, PhD, Hui Gao, PhD, Bang-Ning Lee, PhD, Sergio A. Giralt, MD, Issa F. Khouri, MD, Rima M. Saliba, PhD, Richard E. Champlin, MD, Zeev Estrov, MD
Journal: Blood
Blood (2005) 106 (11): 298.
https://doi.org/10.1182/blood.V106.11.298.298
Published: 2005